SYDNEY and AUCKLAND, New Zealand, Sept. 19, 2013 /PRNewswire/ -- Living Cell Technologies Limited (LCT) today announced that the first patient has been successfully implanted in the Phase I clinical trial of the regenerative cell therapy NTCELL(R) – a potential treatment......
More...
